Brief: Surface Oncology Presents Promising Clinical Data On Srf617 At The European Society For Medical Oncology Immuno-Oncology Congress (Esmo-Io) 2021
06/12/2021 14:31
Dec 6 (Reuters) - Surface Oncology Inc SURF.O :
* SURFACE ONCOLOGY PRESENTS PROMISING CLINICAL DATA ON
SRF617 AT
THE EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY IMMUNO-ONCOLOGY
CONGRESS (ESMO-IO) 2021
Source text for Eikon: ID:nGNX9rDy6R
Further company coverage: SURF.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Surface Oncology
See all newsBrief: Surface Oncology Says Anticipates Will Have Net Cash Of $20 Million To $25 Million At The Closing Of The Proposed Mergers
Surface Oncology Inc reports results for the quarter ended in June - Earnings Summary
Brief: Surface Oncology, Inc. Q2 Net Income USD -28.2 Mln
Surface Oncology Inc expected to post a loss of 34 cents a share - Earnings Preview
Brief: ADAR1 Partners Reports 5.24% Passive Stake In Surface Oncology Inc As Of July 10 - SEC Filing